In addition, EP4 deficiency has been associated with hypercholesterolemia [16] and impaired cardiac fatty acid metabolism [17], whereas EP4 agonists have been shown to prevent diet-induced hypercholesterolemia [16] and improve cardiomyocyte function [17]. The gene discussed is PTGER4; the disease is Hypercholesterolemia.